1-3 of 3
Paul N. Meyer
Close
Sort by
Journal Articles

A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma

Clinical Trials & Observations
Anamarija M. Perry, Teresa M. Cardesa-Salzmann, Paul N. Meyer, Luis Colomo, Lynette M. Smith, Kai Fu, Timothy C. Greiner, Jan Delabie, Randy D. Gascoyne, Lisa Rimsza, Elaine S. Jaffe, German Ott, Andreas Rosenwald, Rita M. Braziel, Raymond Tubbs, James R. Cook, Louis M. Staudt, Joseph M. Connors, Laurie H. Sehn, Julie M. Vose, Armando López-Guillermo, Elias Campo, Wing C. Chan, Dennis D. Weisenburger
Journal: Blood
Blood (2012) 120 (11): 2290–2296.
https://doi.org/10.1182/blood-2012-05-430389
Published: 2012
Includes: Supplemental data
Journal Articles

Concurrent BCL2 and MYC Protein Expression by Immunohistochemistry Determines Clinical Outcome In DLBCL Patients Treated with R-CHOP

Nathalie A Johnson, MD, Ph.D., Joseph M. Connors, MD, Susana Ben-Neriah, Sanja Rogic, Kerry Joanne Savage, MD, BSc, MSc, Christian Steidl, MD, Douglas E Horsman, MD, Graham W. Slack, Laurie Sehn, MD, MPH, Wing-Chung Chan, MD, Javeed Iqbal, Paul N. Meyer, MD, PhD, Georg Lenz, George W Wright, Lisa M. Rimsza, MD, Carlo Valentino, Patrick Brunhoeber, Thomas Grogan, Rita M. Braziel, CAE, MD, James Cook, Raymond R. Tubbs, DO, Dennis D. Weisenburger, MD, Elias Campo, MD, Andreas Rosenwald, German Ott, Jan Delabie, Elaine Jaffe, MD, Louis M. Staudt, MD, PhD, Randy D. Gascoyne, MD
Journal: Blood
Blood (2010) 116 (21): 2005.
https://doi.org/10.1182/blood.V116.21.2005.2005
Published: 2010
Journal Articles

Analysis of In Vitro Effects of Bortezomib (Velcade) on T Cell Prolymphocytic Leukemia (T-PLL).

Fulya Ozpuyan, MD, Paul N. Meyer, MD, Hytham Al-Masri, MD, PhD, Hongyu Ni, MD, Serhan Alkan, MD
Journal: Blood
Blood (2006) 108 (11): 4426.
https://doi.org/10.1182/blood.V108.11.4426.4426
Published: 2006